Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Luminex Corp (NASDAQ:LMNX)

21.54
Delayed Data
As of 4:15pm ET
 +0.03 / +0.14%
Today’s Change
17.68
Today|||52-Week Range
22.27
+6.48%
Year-to-Date
Luminex (LMNX) Banks on FDA Approvals & Portfolio Strength
Nov 16 / Zacks.com - Paid Partner Content
Quest Diagnostics, Clinical Genomics Ally, Oncology Strong
Nov 14 / Zacks.com - Paid Partner Content
Here's Why Investors Should Buy Myriad Genetics Right Now
Nov 16 / Zacks.com - Paid Partner Content
Weight Watchers (WTW) to Issue $500M Senior Notes Due 2025
Nov 14 / Zacks.com - Paid Partner Content
Myriad Genetics' Latest Alliance to Boost GeneSight Reach
Nov 15 / Zacks.com - Paid Partner Content
Medtronic Preliminary Sales Dip Y/Y, Hurricane Blow Lessens
Nov 13 / Zacks.com - Paid Partner Content
DaVita Issues Downbeat '17 View, Hurricanes Affect Q3 Results
Nov 15 / Zacks.com - Paid Partner Content
Bio-Rad (BIO) Beats Earnings and Revenue Estimates in Q3
Nov 13 / Zacks.com - Paid Partner Content
Here's Why Investors Should Buy Luminex (LMNX) Right Now
Nov 15 / Zacks.com - Paid Partner Content
BioTelemetry (BEAT) Q3 Earnings Miss, Revenues Meet Estimates
Nov 13 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close21.51
Today’s open21.50
Day’s range21.39 - 21.74
Volume159,906
Average volume (3 months)168,290
Market cap$947.6M
Dividend yield1.11%
Data as of 4:15pm ET, 11/20/2017

Growth & Valuation

Earnings growth (last year)-62.79%
Earnings growth (this year)+6.73%
Earnings growth (next 5 years)-4.39%
Revenue growth (last year)+13.85%
P/E ratio32.6
Price/Sales3.22
Price/Book2.28

Competitors

 Today’s
change
Today’s
% change
XENTIntersect ENT Inc+0.25+0.88%
ANIKAnika Therapeutics I...+0.58+1.09%
ATRCAtriCure Inc+0.14+0.78%
LMATLeMaitre Vascular In...-0.18-0.52%
Data as of 4:00pm ET, 11/20/2017

Financials

Next reporting dateFebruary 5, 2018
EPS forecast (this quarter)$0.12
Annual revenue (last year)$270.6M
Annual profit (last year)$13.8M
Net profit margin5.10%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Nachum Shamir
Chief Financial Officer, Treasurer &
SVP-Finance
Harriss T. Currie
Corporate headquarters
Austin, Texas

Forecasts